Irritancy & Allergenicity of Topical Ingredients
In disease states such as atopic dermatitis, excipient mildness plays an essential role in topical formulation development due to the skin’s predisposition to irritation and hypersensitivity. Driven by excipient selection, the optimization of patient outcomes and compliance can be achieved through the development of mild topical formulations.
This webinar will explore ingredient mildness and tolerability in relation to sensitive skin and atopic dermatitis. We are pleased to have Dr. Fowler take part in our webinar to discuss his experience in the identification of cutaneous allergy and irritancy through patch testing.
Key Learning Objectives
- Understand how patch testing is used to identify cutaneous allergy and irritancy
- Define sensitive skin and atopic dermatitis
- Comprehend the implications of ingredient mildness and tolerability
- Apply mildness data to develop topical formulations